IP Library Granted Patent US 10,527,544
Granted Patent B2
US 10,527,544 · App. 15/735,661 · Granted Jan 7, 2020

ATR-FTIR for non-invasive detection of colitis

Inventors: Jitto Titus (Acworth, GA); Emilie Viennois (Atlanta, GA); A. G. Unil Perera (Mableton, GA); Merlin Didier (Decatur, GA)
Assignees: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.; THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
G01N21/552A61B5/4255G01N21/3581G01N2021/3595G01N2800/067G01N2800/102
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,527,544
App. No.
15/735,661
Granted
Jan 7, 2020
Kind
B2
Abstract

Disclosed are methods, systems, and apparatuses for non-invasive detection of colitis in a subject. The methods involve depositing a bodily fluid sample from the subject on an internal reflection element (IRE). A beam of infrared (IR) radiation can then be directed through the IRE under conditions such that the IR radiation interacts with the bodily fluid sample. An absorption spectrum can then be recorded over a range of preselected frequencies to detect peaks that are affected by colitis. In preferred embodiments, the methods and systems involve Fourier Transform Infrared Spectroscopy (FTIR).

Claims (12)

1. A method for detecting inflammation in a subject, comprising:

(a) depositing a bodily fluid sample from the subject on an internal reflection element (IRE);

(b) directing a beam of infrared (IR) radiation through the IRE under conditions such that the IR radiation interacts with the bodily fluid sample;

(c) recording an absorption spectrum over a range of preselected frequencies;

(d) comparing the absorption spectrum to a control spectrum to identify spectral events associated with inflammation; and

(e) treating the subject for colitis if an increase in the ratio of 1650:1635 cm −1 peaks compared to a normal control is detected; or treating the subject for arthritis if peaks are detected at 1033 cm −1 but not 1076 cm −1 ; or treating the subject for arthritis if peaks are detected at 1292 cm −1 .

2. The method of claim 1 , wherein the IRE is an attenuated total reflectance (ATR) crystal comprising an optical material with a higher refractive index than the sample.

3. The method of claim 2 , wherein the IRE comprises a germanium crystal or a zinc selenide crystal.

4. The method of claim 1 , wherein the IR radiation that interacts with the bodily fluid sample is an evanescent wave with an average penetration depth of about 2 μm.

5. The method of claim 1 , further comprising Fourier transformation of the absorbance spectrum.

6. The method of claim 1 , wherein the range of preselected frequencies is between 50 cm −1 and 3700 cm −1 .

7. The method of claim 1 , wherein the bodily fluid sample comprises a blood, serum, or plasma sample.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2019
From: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
To: THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 050958/0515 →
CONFIRMATORY LICENSE Recorded Dec 14, 2017
From: GEORGIA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044876/0850 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: TITUS, JITTO; VIENNOIS, EMILIE; PERERA, A.G. UNIL; MERLIN, DIDIER
To: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Reel/Frame 044365/0637 →
Continuity (3)
Provisional Application 62175050 · Jun 12, 2015
Provisional Application 62321542 · Apr 12, 2016
Related Publication 20180364163A1 · Dec 20, 2018